| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Carcinogenesis [D. D. L., M. M. S., K. H. K.], National Cancer Institute, Bethesda, Maryland 20892; The Johns Hopkins University School of Hygiene and Public Health [J. D. G., S. E. L.], Baltimore, Maryland 21205; and Otsuka Pharmaceutical Company [M. M. S.], Rockville, Maryland 20850
The mutagenic spectrum induced by aflatoxin-DNA lesions in DNA repair deficient and repair proficient human cells was investigated. The reactive metabolite aflatoxin B1-8,9-epoxide was synthesized and reacted in vitro with the shuttle vector plasmid pS189. Plasmids were transfected into human fibroblasts and allowed to replicate, and the recovered plasmids were screened in indicator bacteria for plasmid survival and mutations in the supF marker gene. Sequence data were obtained from 71 independently arising mutants recovered from DNA repair deficient xeroderma pigmentosum (XP) cells [XP12BE(SV40)] and 60 mutants recovered from a DNA repair proficient cell line (GM0637). Plasmid survival was lower and mutation frequency higher with the XP cells, and the mutation hotspots differed substantially for the 2 cell lines. Most mutations (>90%) were base substitutions at G:C pairs, only about one-half of which were G:C
T:A transversions, the expected predominant mutation. One-third of the mutations at GG sites and none of those at isolated Gs were G:C
A:T transitions. Tandem base substitutions also occurred only at GG sites and were found only with XP cells. The location of mutation hotspots with either cell line did not correlate with the level of modification within the sequence as assessed by a DNA polymerase stop assay. These results suggest that the DNA repair deficiency associated with XP can influence not only the overall frequency of mutations but also the distribution of mutations within a gene. The finding of transition mutations exclusively at GG sites may be of predictive value in attempts to link dietary aflatoxin exposure to cancers associated with specific mutations in the c-ras oncogene and the p53 tumor suppressor gene.
1 To whom requests for reprints should be addressed.
Received 4/17/92. Accepted 7/29/92.
This article has been cited by other articles:
![]() |
L. L. Bedard, M. Alessi, S. Davey, and T. E. Massey Susceptibility to Aflatoxin B1-Induced Carcinogenesis Correlates with Tissue-Specific Differences in DNA Repair Activity in Mouse and in Rat Cancer Res., February 15, 2005; 65(4): 1265 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. O. Alekseyev, M. L. Hamm, and J. M. Essigmann Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo Carcinogenesis, June 1, 2004; 25(6): 1045 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I.E. McLuckie, M. Gaskell, P. B. Farmer, E. A. Martin, G. D.D. Jones, and M. N. Routledge Effects of the order of exposure to a binary mixture of mutagens on the induced mutation spectra in the supF gene Mutagenesis, March 1, 2004; 19(2): 137 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.P. Wild and P.C. Turner The toxicology of aflatoxins as a basis for public health decisions Mutagenesis, November 1, 2002; 17(6): 471 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Madden, M. J. Finegold, and B. L. Slagle Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice That Express the Hepatitis B Virus X Protein J. Virol., October 11, 2002; 76(22): 11770 - 11774. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Smela, M. L. Hamm, P. T. Henderson, C. M. Harris, T. M. Harris, and J. M. Essigmann The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma PNAS, May 14, 2002; 99(10): 6655 - 6660. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Routledge, K. I. E. McLuckie, G. D. D. Jones, P. B. Farmer, and E. A. Martin Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations Carcinogenesis, August 1, 2001; 22(8): 1231 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis Carcinogenesis, April 1, 2001; 22(4): 535 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Groisman, R. Koshy, F. Henkler, J. D. Groopman, and M. A. Alaoui-Jamali Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells Carcinogenesis, March 1, 1999; 20(3): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |